Call Us: +44 (0) 1752 753723[email protected]

Update on MS patients – 3 years after stem cell transplant

Three years after a small number of patients with multiple sclerosis (MS) were treated with high-dose immunosuppressive therapy (HDIT) and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS (RRMS) and had improvements in neurological function, according to a study...

Grace’s story

As a participant in Duke University’s cord blood clinical trial, Grace – who has cerebral palsy – received an autogloss transplant of cord blood derived stem cells. ¬†Her¬†family were delighted to see a reduction in her symptoms, with significant repair to brain tissue resulting in increased mobility and a...